Submitted by Anonymous (not verified) on 20 November 2023 - 13:06
Human medicines European public assessment report (EPAR): Pegasys, peginterferon alfa-2a, Hepatitis C, Chronic;Hepatitis B, Chronic, Date of authorisation: 20/06/2002, Revision: 46, Status: Authorised
Source: